Screening high-efficiency promoter to construct trans-vp28 vp28 gene Anabaena sp. PCC7120 against white spot syndrome virus of Litopenaeus vannamei

被引:1
|
作者
Chen, Xin-Yu [1 ]
Yu, Dian-Jiang [2 ]
Jia, Rui [1 ,3 ]
机构
[1] Shanghai Ocean Univ, Coll Marine Sci & Ecol Environm, Shanghai 201306, Peoples R China
[2] Xiamen Univ, Coll Life Sci, Xiamen 361104, Peoples R China
[3] Marine Biomed Sci & Technol Innovat Platform Lin G, Shanghai 201306, Peoples R China
关键词
White spot syndrome virus (WSSV); Promoter modifications; vp28; Anabaena sp. PCC7120; Enzyme activities; Litopenaeus vannamei; PENAEUS-MONODON; SUPEROXIDE-DISMUTASE; SYNTHETIC BIOLOGY; EXPRESSION; CYANOBACTERIUM; SHRIMP; ANTIOXIDANT; HEPATOPANCREAS; INFECTION; ENZYMES;
D O I
10.1016/j.fsi.2024.109912
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
This study aimed to select high-quality promoters to construct trans-vp28 gene Anabaena sp. PCC7120 and feed Litopenaeus vannamei to assess the effect of L.vannamei against white spot syndrome virus (WSSV). Transgenic algae were created using five plasmids containing PrbcL, Pcpc560, Ptrc, Ptac, and PpsbA. According to the gene expression efficiency and the growth index of transgenic algae, Pcpc560 was determined to be the most efficient promoter. Shrimps were continuously fed trans-vp28 gene Anabaena sp. PCC7120 for one week and then challenged with WSSV. After the challenge, the transgenic algae group (vp28-7120 group) was continuously immunized [continuous immunization for 0 days (vp28-7120-0d); continuous immunization for 2 days (vp28-7120-2d); continuous immunization for 4 days (vp28-7120-4d)]. After seven days, the daily survival rate of each experimental group was continuously tracked. Following the viral challenge, the hepatopancreas samples were assayed for their levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), thioredoxin peroxidase (TPX), acid phosphatase (ACP), and alkaline phosphatase (AKP) at varying time intervals. In comparison to the positive control group (challenge and no vaccination) and the wild-type group (challenge, fed wild-type Anabaena sp. PCC7120), the vp28-7120 group (challenge, fed trans-vp28 gene Anabaena sp. PCC7120) exhibited a remarkable increase in survival rates, reaching 50 % (vp28-7120-0d), 76.67 % (vp28-7120-2d), and 80 % (vp28-7120-4d). Furthermore, the vp28-7120 group consistently displayed significantly higher activities of SOD, CAT, GSH-Px, ACP, and AKP, while exhibiting notably lower TPX activity, when compared to the control group. These results indicate that the Pcpc560 promoter effectively elevated the expression level of the exogenous vp28 gene and spurred the growth of the trans-vp28 gene Anabaena sp. PCC7120. Consequently, trans-vp28 gene Anabaena sp. PCC7120 significantly bolstered the immunity of L.vannamei. Therefore, utilizing the Pcpc560 promoter to develop trans-vp28 gene Anabaena sp. PCC7120 based oral vaccine is highly beneficial for industrial-scale cultivation, advancing its commercialization prospects.
引用
收藏
页数:7
相关论文
共 47 条
  • [31] Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium
    Ning, Jian-Fang
    Zhu, Wei
    Xu, Jin-Ping
    Zheng, Cong-Yi
    Meng, Xiao-Lin
    VACCINE, 2009, 27 (07) : 1127 - 1135
  • [32] Surface-displayed VP28 on Bacillus subtilis spores induce protection against white spot syndrome virus in crayfish by oral administration
    Ning, D.
    Leng, X.
    Li, Q.
    Xu, W.
    JOURNAL OF APPLIED MICROBIOLOGY, 2011, 111 (06) : 1327 - 1336
  • [33] The effect of liposome-coated recombinant protein VP28 against white spot syndrome virus in kuruma shrimp, Marsupenaeus japonicus
    Mavichak, R.
    Takano, T.
    Kondo, H.
    Hirono, I.
    Wada, S.
    Hatai, K.
    Inagawa, H.
    Takahashi, Y.
    Yoshimura, T.
    Kiyono, H.
    Yuki, Y.
    Aoki, T.
    JOURNAL OF FISH DISEASES, 2010, 33 (01) : 69 - 74
  • [34] Injected phage-displayed-VP28 vaccine reduces shrimp Litopenaeus vannamei mortality by white spot syndrome virus infection
    Solis-Lucero, G.
    Manoutcharian, K.
    Hernandez-Lopez, J.
    Ascencio, F.
    FISH & SHELLFISH IMMUNOLOGY, 2016, 55 : 401 - 406
  • [35] Oral Vaccination of Baculovirus-Expressed VP28 Displays Enhanced Protection against White Spot Syndrome Virus in Penaeus monodon
    Musthaq, Syed S.
    Kwang, Jimmy
    PLOS ONE, 2011, 6 (11):
  • [36] Dual VP28 and VP37 dsRNA encapsulation in IHHNV virus-like particles enhances shrimp protection against white spot syndrome virus
    Weerachatyanukul, Wattana
    Chotwiwatthanakun, Charoonroj
    Jariyapong, Pitchanee
    FISH & SHELLFISH IMMUNOLOGY, 2021, 113 : 89 - 95
  • [37] Generation of microalga Chlamydomonas reinhardtii expressing VP28 protein as oral vaccine candidate for shrimps against White Spot Syndrome Virus (WSSV) infection
    Lanh, Pham Thi
    Nguyen, Huong Minh
    Duong, Bui Thi Thuy
    Hoa, Nguyen Thi
    Thom, Le Thi
    Tam, Luu Thi
    Thu, Ha Thi
    Nha, Vo Van
    Hong, Dang Diem
    Mouradov, Aidyn
    Koyande, Apurav Krishna
    Show, Pau-Loke
    Quyen, Dong Van
    AQUACULTURE, 2021, 540
  • [38] Production of polyclonal antiserum against recombinant VP28 protein and its application for the detection of white spot syndrome virus in crustaceans
    Yoganandhan, K
    Musthaq, SS
    Narayanan, RB
    Hameed, ASS
    JOURNAL OF FISH DISEASES, 2004, 27 (09) : 517 - 522
  • [39] Immune responses of Fenneropenaeus chinensis against white spot syndrome virus after oral delivery of VP28 using Bacillus subtilis as vehicles
    Fu, Ling-Lin
    Shuai, Jiang-Bing
    Xu, Zi-Rong
    Li, Jian-Rong
    Li, Wei-Fen
    FISH & SHELLFISH IMMUNOLOGY, 2010, 28 (01) : 49 - 55
  • [40] Recombinant VP28 Produced by Cell-Free Technique Confers Protection in Kuruma Shrimp (Marsupenaeus japonicus) Against White Spot Syndrome Virus
    Kono, T.
    Fall, J.
    Korenaga, H.
    Sudhakaran, R.
    Biswas, G.
    Mekata, T.
    Itami, T.
    Sakai, M.
    TURKISH JOURNAL OF FISHERIES AND AQUATIC SCIENCES, 2014, 14 (02) : 547 - 555